Successful treatment of pediatric primary hepatic Burkitt lymphoma using rituximab: A case report

Pediatr Blood Cancer. 2021 Dec;68(12):e29259. doi: 10.1002/pbc.29259. Epub 2021 Aug 6.

Authors

Graham Chamberlain¹, Hallie Coltin^{1

2}, Robert J Klaassen^{1

3}, Eden Story^{1

3}, Lesleigh S Abbott^{1

3}

Affiliations

¹ Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
² Hospital for Sick Children, Toronto, Ontario, Canada.
³ Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.

PMID: 34357676
DOI: 10.1002/pbc.29259

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Burkitt Lymphoma* / drug therapy
Burkitt Lymphoma* / pathology
Child
Humans
Rituximab / therapeutic use
Treatment Outcome

Substances

Antibodies, Monoclonal, Murine-Derived
Rituximab